Entera Bio Ltd. (ENTX) — 分析师展望 / 分析师共识目标价为. 基于 4 位分析师评级, 共识为 看涨 — 4 买入.
分析师预估 每股收益(EPS)为 $-0.28 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.25 vs 预期 $-0.28 (超预期 +10.7%). 2025: 实际 $-0.25 vs 预期 $-0.28 (超预期 +10.7%). 分析师准确度: 88%.
ENTX 分析师评级
Buy
基于过去3个月内 4 位分析师对 Entera Bio Ltd. 的评级
EPS 预测 — ENTX
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.25
vs Est –$0.28
▲ 12.0% off
2025
Actual –$0.25
vs Est –$0.28
▲ 12.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — ENTX
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▲ 23.2% off
2025
Actual $0.000B
vs Est $0.000B
▼ 0.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
